Sailish Honap Profile
Sailish Honap

@Sash_Honap

Followers
61
Following
329
Media
0
Statuses
24

Consultant Gastroenterologist at St George's Hospital, London, UK. Clinical Research Fellow in Inflammatory Bowel Disease @KingsCollegeLon and @CHRU_de_Nancy

London, England
Joined June 2020
Don't wanna be here? Send us removal request.
@BettenworthDb
Dominik Bettenworth
1 year
0
13
49
@nathangrellier5
Nathan Grellier
1 year
Early ileal resection in Crohn's disease is not associated with severe long-term outcomes: the ERIC study CD patients from Saint-Antoine and Beaujon Hospital comparing Early vs Late resections https://t.co/HMzNko2fhC @APandT @PSeksik @J_Kirchgesner @h_sokol
6
15
56
@ShomronH
Shomron Ben-Horin
1 year
Whats strikingly shown by this extensive review is that for the most dire situation our UC pts can face (ASUC), there are virtually no industry trials ! Neither is FDA mandating companies to do so. We couldnt even get support for our investigator-initiated ComboMesa trial....!
@Gut_BMJ
Gut Journal
1 year
Read the #RecentAdvancesInClinicalPractice paper by @Sash_Honap et al on "Acute severe ulcerative colitis trials: the past, the present and the future" via https://t.co/Z6xUpi4sA7 @vipuljairath @bruce_sands1 @PDulaiMD @silvio_silvio75 @PeyrinBiroulet #UC #IBD
1
5
27
@BMJOpen_Gastro
BMJ Open Gastro
1 year
Nice paper by @jaya_nish et al on "Associations between prior healthcare use, time to diagnosis, & clinical outcomes in IBD: a nationally representative population-based cohort study" via https://t.co/4drWdvUvGx @RichardPollok @SoniaKSaxena @JonnyBlackwell @DrAlexBottle #BSG2024
0
4
12
@IHU_Infiny
IHU INFINY
1 year
Celebrating World IBD Day with a wave of purple! Big shoutout to the IHU INFINY team and AFA, with special thanks to Mireille. Together, we're stronger! 💜 #WorldIBDDay #PurpleWave #IHUINFINY #PatientSupport
0
6
5
@Intestinal_Cell
Intestinal Cell News
1 year
Check out this new review in 💡 @NatRevDrugDisc! Scientists #review current challenge in 🔥 #IBD drug discovery, and examine how advances in machine learning and tissue engineering could be used at the preclinical stage. 👉 https://t.co/WiVtX7uQbx
0
6
10
@NatRevDrugDisc
Nature Reviews Drug Discovery
1 year
Navigating the complexities of drug development for inflammatory bowel disease https://t.co/1WS6YShyMl This new review discusses how machine learning, organoid models, novel clinical trial designs and digital technologies can address challenges in drug development for IBD
0
11
30
@jennie_clough
Jennie Clough
1 year
How can we get the most out of existing IBD biomarkers, and what does the future of non-invasive IBD monitoring look like? Thanks to @TAGastroenterol for publishing our narrative review @Sash_Honap @RichardPollok @StGeorgesTrust https://t.co/PJS18uZySw
1
15
44
@BritSocGastro
BSG
2 years
We are thrilled to congratulate Dr Sarah Clark on winning the BSG Dame Parveen Kumar for Education and Training Award 2023 for her impressive achievements and work as a trainer! 👏 https://t.co/Hbwi8JgvE2
2
13
55
@TheLancet
The Lancet
2 years
Crohn's disease is a chronic inflammatory disease of the gastrointestinal tract affecting people globally. A new Seminar summarises the key advances of the past decade in the management of Crohn's disease. 🔗 https://t.co/HzHpozyOPx
1
66
176
@FrontGastro_BMJ
Frontline Gastro
2 years
It's time for Round 3! Can you match the tension so far? Two excellent papers! "JAK inhibitors for IBD" https://t.co/yn5zsQ53c1 vs "Minimally invasive endoscopic therapies for GORD" https://t.co/zKK2uBpf9z. @Sash_Honap @RichardPollok @mrsfdonovan @Dr_Nas_Aslam @sheiybani
0
11
16
@FrontGastro_BMJ
Frontline Gastro
2 years
#FGCup: Another paper in the running which has gained lots of attention already: "JAK inhibitors for inflammatory bowel disease". A lovely review of the current JAK inhibitors and a practical guide to their use 👇 https://t.co/yn5zsQ53c1 @Sash_Honap @RichardPollok @mrsfdonovan
2
13
24
@GenelleLunken
Genelle Lunken
2 years
Excited to share the first publication coming out of the Lunken Lab, led by Susanna Meade - systematic review investigating the gut microbiome as a predictive biomarker of response to advanced IBD therapies. @ibdcentrebc @DiscoverIBD #gutmicrobes https://t.co/KBixBN9fcS
Tweet card summary image
tandfonline.com
Loss of response to therapy in inflammatory bowel disease (IBD) has led to a surge in research focusing on precision medicine. Three systematic reviews have been published investigating the associa...
6
12
40
@Shellie_Jean
Shellie Jean Radford
2 years
@BritSocGastro IBD guidelines summit is getting going! A room full of the leaders in IBD care in the UK doing something special today to create the next IBD guidelines led by @GordonMoranIBD and @drmorrisgordon and team!
0
2
25
@MadhoorRamdeen
Madhoor Ramdeen
2 years
And that's a wrap! Two days of intense discussions, grading & formulating the next @BritSocGastro #IBD guidelines. IBD colleagues from across the 4 nations & patient #advocates collaborating to produce the best evidence based treatment & care for those with #CD & #UC. #TeamIBD
3
7
31
@RichardPollok
Prof Richard Pollok
2 years
We hope this is usefulChronic abdominal pain in #IBD : a practical guide @SammieBaillie @SoniaKSaxena@IBDBOOST⁩ ⁦@FrontGastro_BMJ⁩ ⁦@ChristianSelin3⁩ ⁦@alex_ford12399 @SGH_IBD@RichardPollok#Pain
1
12
19
@bottomlineibd
The Bottom Line IBD
2 years
JAK inhibitors for the treatment of #IBD: results of an international survey of perceptions, attitudes and clinical practice.
0
1
7